p27 Cell-cycle inhibitor is inversely correlated with lymph node metastases in right-sided colon cancer

Journal of Clinical Laboratory Analysis

Volumn 13, Issue 6, 1999, Pages 291-295

  Liu, Dong Feng ^a   Ferguson, Kelly ^a   Cooper, Gregory S ^b   Grady, William M ^b   Willis, Joseph ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colon cancer; Immunostaining; Lymph node metastasis; P27

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P27;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL CYCLE; CLINICAL ARTICLE; COLON CANCER; DIGESTIVE SYSTEM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; METASTASIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; CELL CYCLE PROTEINS; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; HUMANS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PROGNOSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0007809476     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1999)13:6<291::AID-JCLA7>3.0.CO;2-K     Document Type: Article

References (47)

1. The American Cancer Society: Cancer facts & figures - 1999.
2. Jass JR, Atkin WS, Cuzick J, Bussey HJR, Morson BC, Northover JMA, Todd IP. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathol 1986;10:437-459.
3. Shepherd NA, Saraga EP, Love SB, Jass JR. Prognostic factors in colonic cancer. Histopathol 1989;14:613-620.
4. Griffin MR, Bergstralh EJ, Coffey RJ, Beart Jr RW, Melton III LJ. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 1987;60:2318-2324.
5. Newland RC, Chapuis PH, Smith, EJ. The prognostic value of substaging colorectal carcinoma. A prospective study of 1117 cases with standardized pathology. Cancer 1987;60:852-857.
6. Newland RC, Dent OF, Lyttle MNB, Chapuis PH, Bokey EL. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 1994;73:2076-2082.
7. Spratt JS Jr, Spjut HJ. Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma. Cancer 1967;20:1976-1985.
8. Steinberg SM, Barkin JS, Kaplan RS, Stablein DM. Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group Experience. Cancer 1986;57:1866-1870.
9. Steinbery SM, Barwick KW, Stablein DM. Importance of tumor pathology and morphology in patients with surgically resected colon cancer. Findings from the 10. Gastrointestinal Tumor Study Group. Cancer 1986;58:1340-1345.
10. Mayer RJ. Chemotherapy for metastatic colorectal cancer. Cancer 1992;1:70(5 Suppl.), 1414-1424.
11. O'Connell MJ, Martenson JA, Wieand HS. et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994; 331:502-507.
12. Polyak K, Lee MH, Erdjument-Bromage A, et al. Cloning of p27, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signal. Cell 1994;78:59-69.
13. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994;78:67-74.
14. Kato JY, Matsuoka M, Polyak K, Massague J, Sherr, CJ. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27kip1) of cyclin-independent kinase 4 activation. Cell 1994;79:487-496.
15. Nourse J, Firpo F, Flanagan MW, et al. Interleukin-2-mediated elimination of the p27kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (Lond) 1994;372:570-573.
16. Kranenburg O, Scharnhorst V, Van der Eb A, Zantema A. Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells. J Cell Biol 1995;131:227-235.
17. Hengst L, Reed SI. Translation control of p27kip1 accumulation during the cell cycle. Science (Washington DC) 1996;271:1861-1864.
18. Han EKH, Begemann M, Sgambato A, et al. Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1. inhibits growth, and enhances apoptosis. Cell Growth Differ 1996;7:699-710.
19. Doki Y, Imoto M, Han EK, Sgambato A, Weinstein IB. Increased expression of the p27kip1 protein in human esophageal cancer cell line that over-express cyclin D1. Carcinogenesis 1997;18:1139-1148.
20. Anayama T, Furihata M, Ishikawa T, Ohtsuki Y, Ogoshi S. Positive correlation between p27kip1 expression and progression of human esophageal squamous cell carcinoma. Int J Cancer 1998;79:439-443.
21. Yasui W, Kudo Y, Semba S, Yokozaki H, Tahara E. Reduced expression of cyclin-dependent kinase inhibitor p27kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn J Cancer Res 1997;88:625-629.
22. Cheville JC, Lloyd RV, Sebo TJ, et al. Expression of p27kip1 in prostatic adenocarcinoma. Mod Pathol 1998;11:324-328.
23. Cote RJ, Shi Y, Groshen S, et al. Association of p27kip1 levels with recurrence and survival in patients with stage C prostate carcinoma. J Natl Cancer Inst 1998;17:916-920.
24. Tsihlias J, Kapusta LR, DeBoer G, et al. Loss of cyclin-dependent kinase inhibitor p27kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res 1998;58:542-548.
25. Gorospe M, Liu Y, Xu Q, Chrest FJ, Holbrook NJ. Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cell by prostaglandin A2. Mol Cell Biol 1996;16:762-770.
26. Fredersdorf S, Bums J, Milne AM, et al. High level expression of p27 and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27 and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci U S A 1997;94:6380-6385.
27. Tan P, Cady B, Wabber M, et al. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a, b) invasive breast carcinomas. Cancer Res 1997;57:1259-1263.
28. Kawana H, Tamaru J, Tanaka T, et al. Role of p27kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer. Am J Pathol 1998;153:505-513.
29. Resnick MB, Schacter P, Finkelstein Y, Kellner Y, Cohen O. Immunohistochemical analysis of p27kip1 expression in thyroid carcinoma. Mod Pathol 1998;11:735-739.
30. Thomas GV, Szigeti K, Murphy M, Draetta G, Pagano M, Loda M. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am J Pathol 1998;153:681-687.
31. Kashtan H, Verbin N, Aladjem D, Barak Y, Wiznitzer T. Right and left colon carcinoma: a retrospective comparative study. J Surg Oncol 1987;35:245-248.
32. Geelhoed GW, Crossland SG. Carcinoma of the right colon: a change in characteristic configuration? South Med J 1981;74:1436-1438.
33. Erba M, Boneschi M, Eusebio D, Giuffrida GF. Prognostic clinical and anatomopathological factors in surgery of carcinoma of the right colon. Minerva Chir 1997;52:727-733.
34. Liu DF, Grady WM, Rajput A, Markowitz S, Willis J. p27 expression inversely correlates with microsatellite instability and TGF-beta receptor mutations in sporadic colon cancer. New Orleans: Annual Meeting of the AGA and AASLD, May 16-22, 1998.
35. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Robert JM, Koff A. p27kip1, a cyclin-Cdk inhibitor, links transforming growth factor beta and contact inhibition to cell cycle arrest. Genes Dev 1994;8:9-22.
36. Iacopetta BJ, Welch J, Soong R, House AK, Zhor XP, Hamelin R. Mutation of the transforming growth factor-beta type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterations. Am J Pathol 1998;184:390-395.
37. Grady WM, Rajput A, Myeroff L, et al. Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res 1998;58:3101-3104.
38. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1990;15:119-188.
39. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors: International Union Against Cancer 5th ed. New York, NY: Wiley; 1997.
40. Ciaparrone M, Yamamoto H, Yao Y, et al. Localization and expression of p27 in multistage colorectal carcinogenesis. Cancer Res 1998; 58:114-122.
41. Werner M, Von Wasielewski R, Komminoth P. Antigen retrieval, signal amplification and intensification in immunohistochemistry. Histochem Cell Biology 1996;105:253-260.
42. Falini B, Taylor C. New developments in immunoperoxidase techniques and their applications. Arch Pathol Lab Med 1983;107: 105-117.
43. Kim H, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994;145:148-156.
44. Messerini L, Vitelli F, De Vitis LR, et al. Microsatellite instability in sporadic mucinous colorectal carcinomas: relationship to clinico-pathological variables. J Pathol 1997;182:380-384.
45. Akiyama Y, Iwannaga R, Ishikawa T. et al. Mutation of the transforming growth factor-beta type II receptor gene are strongly related to sporadic proximal colon carcinomas with microsatellite instability. Cancer 1996;78:2478-2484.
46. St. Croix B, Sheehan C, Rak JW, Florences VA, Slingerland JM, Kerbel RS. E-Cadhern-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27. J Cell Biol 1998; 142:557-571.
47. Prall OWJ, Sarcevic B, Musgrove EA, Watts CKW, Sutherland RL. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J Biol Chem 1997;18:10882-10894.